Skip to main content
. 2011 Oct 17;60(11):3067–3072. doi: 10.2337/db10-0560

FIG. 1.

FIG. 1.

C-peptide values (fasting, maximal, and AUC) during 12 months of follow-up in subjects treated with DiaPep277 or placebo, according to the HLA risk genotype. A: Adults with type 1 diabetes. B: Children with type 1 diabetes. ■, high/moderate risk genotype, placebo treated (n = 19 adults and n = 25 children); □, low risk genotype, placebo treated (n = 5 adults and n = 7 children); ●, high/moderate risk genotype, DiaPep277 treated (n = 33 adults and n = 36 children); ○, low risk genotype, DiaPep277 treated (n = 13 adults and n = 8 children).